Benitec Biopharma Revenue and Competitors
Estimated Revenue & Valuation
- Benitec Biopharma's estimated annual revenue is currently $3.1M per year.
- Benitec Biopharma's estimated revenue per employee is $155,000
Employee Data
- Benitec Biopharma has 20 Employees.
- Benitec Biopharma grew their employee count by 11% last year.
Benitec Biopharma's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | SVP Manufacturing | Reveal Email/Phone |
3 | Executive Director | Reveal Email/Phone |
4 | Scientist I | Reveal Email/Phone |
5 | Senior Scientist | Reveal Email/Phone |
6 | Senior Research Associate II | Reveal Email/Phone |
7 | Senior Research Associate I | Reveal Email/Phone |
8 | Senior Scientist | Reveal Email/Phone |
9 | Scientist | Reveal Email/Phone |
Benitec Biopharma Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Benitec Biopharma?
Benitec is a biotechnology company developing a proprietary therapeutic technology platform that combines RNA interference (RNAi) with gene therapy with a goal of providing sustained, long-lasting silencing of disease-causing genes from a single administration. Benitec is using its technology, called DNA-directed RNA interference (ddRNAi) to develop a pipeline of product candidates for the treatment of several chronic and life-threatening human diseases , including oculopharyngeal muscular dystrophy (OPMD) and hepatitis B. By combining the specificity and gene silencing effect of RNAi with gene therapy, ddRNAi has the potential to produce long-lasting silencing of disease-causing genes from a single administration, which could minimize the requirement for patients to take regular doses of medicine. Benitec’s objective is to become the leader in discovering, developing, clinically validating and commercializing ddRNAi-based therapeutics for a range of human diseases with high unmet clinical need or large patient populations and, as a result, provide a better life for patients with these diseases.
keywords:N/AN/A
Total Funding
20
Number of Employees
$3.1M
Revenue (est)
11%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2M | 20 | -23% | N/A |
#2 | $1.6M | 21 | 0% | N/A |
#3 | $3.3M | 21 | -36% | N/A |
#4 | $3.1M | 21 | -12% | $101.5M |
#5 | $7.5M | 21 | -5% | N/A |